Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation

Circulation Research

Volumn 93, Issue 5, 2003, Pages 399-405

  Geraldes, Pedro ^a,b   Sirois, Martin G ^a   Tanguay, Jean François ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

17 estradiol; Estrogen receptors; Mitogen activated protein kinase; Vascular cells

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOROTHIOIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ESTROGEN ACTIVITY; GENE INDUCTION; GENE THERAPY; HEART PROTECTION; HORMONE SUBSTITUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM;

ANIMALS; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; OLIGONUCLEOTIDES, ANTISENSE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, ESTROGEN; RNA, MESSENGER; SWINE;

EID: 0042416621     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000088640.18462.42     Document Type: Article

References (25)

1. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association Writing Group. Circulation. 1997;96:2468-2482.
2. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health. 1998;19:55-72.
3. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75: 1102-1109.
4. Koh KK. Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc Res. 2002;55:714-726.
5. Haynes MP, Li L, Russell KS, Bender JR. Rapid vascular cell responses to estrogen and membrane receptors. Vasc Pharmacol. 2002;38:99-108.
6. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613.
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
8. Luconi M, Forti G, Baldi E. Genomic and nongenomic effects of estrogens: molecular mechanisms of action and clinical implications for male reproduction. J Steroid Biochem Mol Biol. 2002;80:369-381.
9. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
10. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V. Cloning chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol. 1997;11: 353-365.
11. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME. Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res. 2002;90:1087-1092.
12. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science. 2002;295:505-508.
13. Chandrasekar B, Tanguay JF. Local delivery of 17-β-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. J Am Coll Cardiol. 2000;36:1972-1978.
14. Chandrasekar B, Nattel S, Tanguay JF. Coronary artery endothelial protection after local delivery of 17β-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function. J Am Coll Cardiol. 2001;38:1570-1576.
15. Keshamouni VG, Mattingly RR, Reddy KB. Mechanism of 17-β -estradiol-induced Erk1/2 activation in breast cancer cells: a role for HER2 and PKC-δ. J Biol Chem. 2002;277:22558-22565.
16. Geraldes P, Sirois MG, Bernatchez PN, Tanguay JF. Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol. 2002;22:1585-1590.
17. Arnal JF, Bayard F. Alteration in endothelial estrogen receptor expression: a potential key of vasculoprotection by estrogens? Circ Res. 2002;91:759-760.
18. Inamdar SR, Eyster KM, Schlenker EH. Estrogen receptor-α antisense decreases brain estrogen receptor levels and affects ventilation in male and female rats. J Appl Physiol. 2001;91:1886-1892.
19. Bai Y, Giguere V. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. Mol Endocrinol. 2003;17:589-599.
20. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG, Kushner PJ. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem. 2002;277: 24353-24360.
21. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME. Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res. 1998;83:224-229.
22. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β. Circulation. 2001;103: 423-428.
23. Levin ER. Cellular functions of plasma membrane estrogen receptors. Steroids. 2002;67:471-475.
24. Zhang Z, Maier B, Santen RJ, Song RX. Membrane association of estrogen receptor α mediates estrogen effect on MAPK activation. Biochem Biophys Res Commun. 2002;294:926-933.
25. Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME, Shaul PW. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res. 2002;91:814-820.